Strainprint™ Technologies Ltd. Welcomes 48North Cannabis Co. parent company of ACMPR Licensed Producer Delshen Therapeutics

TORONTO, Dec. 21, 2017 /CNW/ – Strainprint™ – the leader in cannabis data collection and strain efficacy reporting – is excited to announce that 48North Cannabis (48North) has subscribed to Strainprint’s world-leading cannabis data & analytics platform to help guide its operational growth and product development.

48North’s Ontario-based cultivation facility Delshen Therapeutics is a Health Canada Licensed Producer with unique genetics sourced from the Netherlands’ first cannabis license holder, MariPharm B.V. 48 North plans to use Strainprint’s data and analytics tools to support the existing medical research on their proprietary strains and to develop cannabis products and brands that meet the needs of a variety of consumers.

“Strainprint’s unique ACMPR strain efficacy and patient use data will help us to produce the highest quality products that will support our patients and recreational consumers in navigating their cannabis experiences.,” said Alison Gordon, 48North CEO.

Thousands of ACMPR patients have tracked almost 150,000 medication sessions from our industry-leading mobile app generating over 4 million data points on strain efficacy and patient use.  It is the largest and most granular longitudinal data set in the world on strain efficacy and patient use of lab-verified products.  In addition to guiding patients, this data is helping to shape the entire cannabis industry by providing business intelligence for all stakeholders, including licensed producers, doctors and clinics, researchers, pharma and insurance providers.

“Our mission is to help our users and our subscriber customers to better understand how cannabis works and how it can best be used for whatever their purpose.  We are ecstatic to be working with 48North to provide them with the most reliable source of data that will be instrumental for developing premium products for their consumers and patients,” said Strainprint CEO, Andrew Muroff.

The Strainprint mobile App is free and is available for both iOS & Android from the Apple iTunes and Google Play Stores, respectively.

About Strainprint™

Founded in Toronto in 2016, Strainprint™ Technologies Ltd. is the leading demand-side cannabis data and analytics company, gathering real-time cannabis consumption and efficacy data on lab-verified strains, while providing enterprise business intelligence to the global cannabis industry. Strainprint™ data supports global cannabis research and provides advanced business intelligence to producers, retailers, medical practitioners, pharma, government and industry. Strainprint is HIPAA, PIPEDA and PHIPA privacy compliant, military-grade encrypted and all patient data is completely anonymized and at rest in Canada. Strainprint can be seamlessly embedded or integrated with most electronic medical records (EMR) and seed2sale software systems. The Strainprint App is free to patients and can be downloaded from both the iOS App Store and GooglePlay Store. For more information visit www.strainprint.ca, facebook, twitter, linkedin

About 48 North

48North is a vertically integrated cannabis company. Its first ACMPR licensed facility is located on 800 acres of owned land near Kirkland Lake, Ontario, and is operated by its wholly-owned subsidiary, DelShen Therapeutics. The company grows unique genetics sourced from MariPharm B.V., a Netherlands based phytopharmaceutical company with over 25 years of experience in the research and cultivation of cannabis for medical purposes. The genetics are grown to exacting standards in DelShen’s state-of-the-art, closed box facility, ensuring patients can count on receiving the highest quality cannabis products. 48North’s values are rooted in the land they’re planted on, and the company has entered into a first of its kind Community Benefits Agreement with certain of its First Nations investors.

SOURCE Strainprint™ Technologies Ltd.

Media Contact

Jessica Moran
519-494-5379
Strainprint Technologies Ltd.
jessica.moran@strainprint.ca

5 Unique Facts About Cannabidiol (CBD)

When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.

THC, or tetrahydrocannabinol is responsible for the psychoactive effect of cannabis; this is the cannabinoid that gets users “high”.

CBD, or cannabidiol, is one of the most powerful parts of the cannabis plant due to its healing properties. CBD is widely lauded in the medical marijuana community for its effectiveness in helping users experience relief from many medical-related ailments and issues.

Here are 5 unique facts about cannabidiol that have people talking:

  1. CBD does not get you high

One of the misconceptions about CBD has been that since it’s a derivative from the cannabis plant, it must get you high. Further confusion was brought about last year in the USA when the DEA classified CBD as a Schedule 1 drug, arousing the cannabis and hemp-based community globally to clear the smoke on exactly what CBD is.

Those who are using medical marijuana often look for high-CBD strains to bring out the positive therapeutic effects reported by CBD users, particularly in its application to aid in the relief of anxiety and depression, PTSD and insomnia, among other health issues.

  1. CBD and THC work in interesting ways

In the medical marijuana community, the role of THC is often up for debate and much concern because of the way THC and CBD can interact with each other in certain contexts.

For instance, if someone is using a strain with an equal CBD to THC ratio recommended to combat feelings of anxiety, the CBD will work to counteract the feelings of paranoia that THC can often induce.

Similarly, THC has been said to alter the painkilling properties of CBC, which shows an important interaction between these compounds and how the one can support the other in therapeutic cannabis situations.

The ways that THC and CBD interact are being further researched and experiences continue to be shared about how different THC:CBD strain ratios work together.

  1. CBD is both hemp-derived and marijuana-derived

You’ll often see CBD advertised in two main formats: hemp-derived CBD and marijuana-derived CBD. Both from the cannabis plant, hemp and marijuana serve different functions and are approached with different legalities.

For the most part, hemp-based CBD is not illegal and can be found in health-food stores and can be purchased online. These derivatives do not contain any of the THC that could be present in marijuana-derived CBD, and if they do, it’s in extremely small trace amounts that have no effect on the user.

Hemp-based CBD are up for debate in terms of their effectiveness in comparison to marijuana-based CBD. While both hemp and marijuana contain CBD, the marijuana plant contains a higher level of CBD for increased therapeutic and healing properties. As mentioned above, marijuana-based CBD is also lauded for its interaction with THC and how the CBD effects can be enhanced.

Nonetheless, hemp-based CBD are making its way into popular discourse, particularly in sports, where recently, the World Anti-Doping Agency removed hemp-based CBD from its list of prohibited substances. This move came after MMA fighter Nate Diaz was seen “vaping” hemp-CBD and opened the dialogue about its healing properties against the inflammation and pain caused to athletes by their sports.

  1. CBDs are showing promise for mental health

While it’s usually recommended that those suffering from mental health issues like anxiety and depression stay away from high-THC strains, high-CBD strains are showing promise for the relief of depression, anxiety, and PTSD.

Scientifically, most of the research on CBDs are in “pre-trial” phases, or clinical studies are being completed with experimental animals (i.e. rats), but early data is showing that CBD can help the brain transmit more serotonin signals, reducing anxiety and boosting mood.

Other preliminary studies are looking at how CBD can help the hippocampus, the part of the brain responsible for memory and cognition, regenerate neurons, as science has already suggested the birth of new hippocampal neurons can be what’s needed in the treatment of depression.

CBD is also becoming extremely common in communities who are combating PTSD. The preliminary research on the endocannabinoid receptors in the brain is showing how CBD can play a role in “normal fear-extinction”. Research is mostly hinged on the belief that CBD can interrupt the signals in the amygdala-hippocampal-cortico-striatal circuit, which is the primary brain function coordinates fear-related memories and brings the body to respond to fear-related behaviours.

Because of the connection between anxiety, depression, and PTSD to sleep patterns, sleep specialists have begun to look at CBD as a relief for insomnia, where the CBD stimulates alertness during the daytime hours and simulates fatigue during the nighttime hours. Those who laud the benefits of CBD on insomnia report a regulated sleep schedule, more time spent sleeping, and an overall improvement in sleep quality.

  1. CBD Can Be Introduced Into Your Body in Various Ways

The key to the effectiveness of CBD is your body’s own endocannabinoid system, which is nature’s way of showing us that our bodies have been created to benefit from the cannabis plant when introduced.

Cannabinoid receptors are found all over the human body. CB1 receptors are found in the central nervous system. CB2 receptors are more often found in immune cells, your digestive tract, and in your peripheral nervous system. Therefore there are many ways CBD can be introduced into your endocannabinoid system:

  • Orally – Through ingesting CBD through tinctures, oils, or drops that can be ingested under the tongue or added to your food
  • Topically – By using CBD-infused salves, massage oils, and ointments that allow your skin to absorb the CBD
  • Vaporizing – Inhaling active CBD through your lung tissues by way of a vaporizer
  • Anally or Vaginally – CBD suppositories have been developed by LPs to allow people to gain the benefits of CBD through the anal or vaginal membranes

Explore CBD with Strainprint

If you’re interested in seeing how CBD-products and CBD-rich cannabis strains can enhance your health and lifestyle, check out the Strainprint app. By entering in some of the symptoms you are experiencing, you’ll be brought to real-time data that will help you learn which strains, ingestion methods, and dose will work best for finding relief. The best part is that you can provide your feedback to other users of CBD strains who are relying on user’s experiences to help them make decisions about their cannabis strains.

Strainprint™ Technologies Ltd. Launches Custom-Branded OEM Version of Industry-Leading Mobile Cannabis Journaling App for Canna Farms

TORONTO, Nov. 21, 2017 /CNW/ – Strainprint™ — the leader in cannabis data collection and strain efficacy reporting — is pleased to announce the release of the Canna Farms OEM version of the Strainprint mobile App. The newest custom-branded version of the Strainprint App is available exclusively for Canna Farms customers through a unique activation code.

Canna Farms is a Health Canada Licensed Producer (“LP”) of craft cannabis products, and the first ACMPR LP in British Columbia. “We are very excited about having this branded version of the Strainprint App as it will create an easy and efficient way for our customers to track their cannabis usage and determine what strains work best for them,” said Canna Farms’ President, Ray Laflamme.

In addition to helping build the Canna Farms community, the exclusive version of the App sets Canna Farms apart from other LPs. “We’re thrilled to be working with the Canna Farms team. They truly understand the value of incorporating technology to better communicate with their customers and expand their reach while using Strainprint as a key component,” said Evan Karasick, Strainprint’s Chief Product Officer.

Strainprint offers custom-branded versions of its mobile App for producers, clinics, researchers and industry. This enables rapid community development through prompted messaging and configurable loyalty engagement in compliance with Health Canada regulations.

The Strainprint mobile App is free and is available for both iOS & Android from the Apple iTunes and Google Play Stores, respectively. Canna Farms’ customers will receive a unique code to activate the additional features.

About Strainprint™

Founded in Toronto in 2016, StrainprintTM Technologies Ltd. is the leading demand-side cannabis data and analytics company, gathering real-time cannabis consumption and efficacy data on lab-verified strains, while providing enterprise business intelligence to the global cannabis industry. StrainprintTM data supports global cannabis research and provides advanced business intelligence to producers, retailers, medical practitioners, pharma, government and industry. Strainprint is HIPAA, PIPEDA and PHIPA privacy compliant, military-grade encrypted and all patient data is completely anonymized and at rest in Canada. Strainprint can be seamlessly embedded or integrated with most electronic medical records (EMR) and seed2sale software systems. The Strainprint App can be downloaded from both the iOS App Store and GooglePlay Store. For more information visit www.strainprint.ca.

About Canna Farms

Canna Farms is a Health Canada Licensed Producer of craft cannabis products and was the first ACMPR Licensed Producer in British Columbia. Their team is dedicated to providing patients with exceptional cannabis products at an affordable price.

Canna Farms, 1-855-882-0988, www.cannafarms.ca

SOURCE Strainprint™ Technologies Ltd.

Media Contact

Jessica Moran
Strainprint™ Technologies Ltd
jessica.moran@strainprint.ca
(519) 494-5379